Michael H. Bellm
Founder & President, Aseptic Enclosures
Michael H. Bellm is the Founder and President of Aseptic Enclosures, A St. Louis-based manufacturer and solutions provider specializing in cleanroom and containment systems for sterile compounding environments. With roots in aseptic pharmaceutical production dating back to 1987, Michael brings nearly four decades of hands-on expertise to every project he touches.
He founded Aseptic Enclosures in 1992 with a focus on parenteral production within cGMP-compliant, FDA-registered pharmaceutical manufacturing facilities. In 2005, he expanded the company’s mission into the pharmacy sterile compounding market, pioneering the introduction of Compounding Aseptic Isolators(CAIs) and Compounding Aseptic Containment Isolators (CACIs) to a rapidly evolving industry. Today, AsepticEnclosures offers one of the most comprehensive product and service portfolios available to multinationals, independent copounding pharmacies, and research startups.
Under Michael’s leadership, the company has guided hundreds of compliance projects for hospitals, compounding pharmacies, and biotech firms nationwide. The Aseptic Enclosures product line spans custom-engineered isolators, modular and portable cleanrooms, HEPA filtration systems, fan filter units, negative-pressure rooms, particle counters, and environmental monitoring systems, including the company’s recently launched patent-pending XLTC isolator line and the new AE Clean Room Monitor (CRM) product series.
Beyond equipment, Michael has built a full-service consultancy model. His team provides pharmacy planning and design, detailed facility design, GAP analysis, compliance auditing, computational fluid dynamics analysis, CAD and SolidWorks layouts, validation support, microbiological and sterility testing, and on-site cleanroom training, covering everything from gowning competency to hazardous drug handling under USP 800.
His client roster reflects the breadth and trust he has earned in the field, including institutions such as Johns Hopkins, the National Institutes of Health (NIH), the U.S. Department of Veterans Affairs, BJC Healthcare, Ascension Health, Labcorp Drug Development, AbbVie, and SSM Health, among many others.
